What is the Tom Brady dog clone company
The company associated with Tom Brady and cloned dogs is ViaGen Pets, a commercial pet cloning and genetic preservation business. In 2021, tabloids reported that Brady and supermodel Gisele Bündchen had cloned their dog, a process handled by ViaGen Pets. The reports described how ViaGen generates a genetic copy of a pet using cell material from the original animal. While celebrity involvement is often highlighted, the more significant story is how pet cloning has become a repeatable, if costly, service for pet owners seeking to replicate a companion animal.
Pet cloning does not recreate temperament or memories; it creates a genetically similar embryo implanted into a surrogate. As the topic resurfaces in media and conversations, it is useful to understand the company, the process, and the realities for pet owners considering this option.
How pet cloning works
Commercial pet cloning involves several steps carried out by a specialized facility. The process begins with cell collection from the original pet, followed by preservation and transfer to a cloning facility, where a somatic cell nuclear transfer (SCNT) procedure creates an embryo. The embryo is then transferred into a surrogate mother, carried to term, and the resulting puppy or kitten is returned to the owner. The timeline spans months, and success is not guaranteed, as surrogacy and implantation complications can alter outcomes.
Because a clone shares the same nuclear DNA, it is often assumed the pet will behave identically. In practice, genetics is only one factor influencing behavior. Environment, upbringing, and early experiences play major roles. For many owners, the decision to clone is emotional rather than practical, driven by grief and the desire to preserve a bond rather than obtain an identical replacement.
ViaGen Pets overview
ViaGen Pets is a commercial cloning company that also offers genetic preservation services, allowing owners to store cells from pets for future use. The company positions cloning as an option for cherished animals when breeding or natural reproduction is not feasible. It is one of the few providers in North America that performs full-service pet cloning, handling cell culture, embryo development, and surrogate care. While ViaGen Pets is the company named in connection with Tom Brady, the same technical process applies to other commercial pet-cloning providers.
Here is a simplified overview of how a pet cloning package typically progresses.
| Stage | Key Details | Typical Outcome |
|---|---|---|
| Cell collection | Painless biopsy of tissue or cheek swab | Genetic material stored and cultured |
| Preservation and shipping | Controlled-temperature transport to facility | Cells remain viable for processing |
| SCNT and embryo culture | Transfer of donor nucleus into egg cell | Created embryo(s) for transfer |
| Surrogate implantation | Embryo placed into a prepared surrogate | Pregnancy initiated (not guaranteed) |
| Pregnancy and birth | Surrogate carried the pregnancy to term | Cloned puppy or kitten delivered |
| Post-birth care and return | Health checks and owner reunion | Customer receives cloned pet |
Costs and what’s included
Pet cloning is a premium service, with total packages often ranging into five figures. Costs cover consultations, cell collection, genetic preservation, laboratory work, surrogate care, pregnancy monitoring, and the return of the cloned pet. Additional fees may apply if multiple attempts are required or if surrogates need medical support. Many companies also offer packages that include genetic storage, which can reduce the overall price if cloning is pursued later. Exact pricing varies by provider and animal size, and prospective clients should request detailed breakdowns before committing.
Ethical, medical, and behavioral considerations
Pet cloning raises ethical questions related to animal welfare, the use of surrogates, and the expectations of pet owners. Cloned animals may face health issues, as the process does not guarantee a perfectly healthy or long-lived pet. Behavioral outcomes are especially unpredictable; while genetics influence traits, upbringing and environment are decisive. Owners should plan for a new individual with a unique personality rather than an identical copy. Veterinary oversight, transparency from the provider, and realistic expectations are essential when considering cloning.
What has been confirmed versus speculation
Confirmed details include that ViaGen Pets was the company referenced in media reports about the Brady dog clone story. These reports stated that the cloning process occurred through ViaGen’s services. Celebrity names often drive headlines, but the underlying service is a commercial cloning operation available to any pet owner who meets the medical and logistical requirements. Speculation typically exaggerates the process as an easy or foolproof solution, whereas the reality involves significant cost, time, uncertainty, and ethical reflection.
Key takeaways
- ViaGen Pets is the commercial pet-cloning company linked to the Tom Brady dog clone reports.
- Pet cloning uses SCNT to create a genetically similar embryo, not a behaviorally identical copy.
- The process is costly, technically complex, and involves health and ethical considerations.
- Success is never guaranteed, and cloned pets are unique individuals shaped by both genetics and environment.
- Consumers should obtain clear pricing, references, and medical transparency before using a pet-cloning service.
For pet owners weighing this option, the most practical approach is to treat cloning as one among several ways to honor a companion animal. Combining genetic preservation with veterinary guidance and realistic expectations yields the best path forward.